tykhr
sign in
free sign up
Evotec SE ADR
Drug Manufacturers - Specialty & Generic
Healthcare
EVO
355 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.64
52 week high
5.55
high
3.69
52 week low
0.00
low
3.64
growth
8.55 %
previous Close
3.75
P/E ratio
market cap
1.22 B
div yield
0
usd
Jun 2025
qoq
revenue
171 M
-14.37 %
net incoming
-43.48 M
-37.69 %
eps
0.00 %
-16.95 %
eps surprise
-115.14 %
net profit margin
-25.39 %
-9.00 %
operating incoming
-27.77 M
-38.81 %
net change in cash
-17.55 M
16.46 %
cash on hand
268 M
-6.15 %
cost of revenue
163 M
-5.85 %
top